Tom Mone is the Chief Executive Officer of One Legacy, US’s largest organ recovery agency, serving 19.5 million people, 200+ hospitals and 11 transplant centers. OneLegacy annually recovers 400+ organ donors, 1,300+ organs for transplant and 2,000+ tissue donors; each a 60-100% increase since he arrived at OneLegacy. Mr. Mone has led the development of the first donation field invention and use of 1) electronic donor records and web-based organ placement system, 2) real-time nucleic acid testing of all donors, 3) the Donate Life California DMV-linked Registry, 4) the Living Donation California Referral program 5) donor coordinator role specialization, 6) Spanish language paid media advertising, 7) multilingual family care staff, 8) created the world’s largest tissue recovery program, and 9) created the world’s largest public promotion of donation by creating the Donate Life Rose Parade Float that has 100+ national and international partners and is seen by 30 million+ people each year.
Pros/Cons of the Opt-In Donation System: An International Panel Discussion
The Alliance Conversation Series brings you cost-free, fast-paced collaborative opportunities that highlight successful donation and transplantation practices across the country. Through shared insight, multidisciplinary experts identify solutions to critical challenges affecting the community of practice and actively share them for open discussion and broader knowledge of effective practices.
Sessions are designed to be approximately 30-45 minutes in length and encourage real-time feedback and participation from viewers.
Overview: There has been an increasing number of discussions about the benefits of an Opt-out vs. Opt-in organ donation system and its effects on organ donation rates. Other countries have experienced increasing donation rates; however, would the same impact materialize in the United States?
We will hear from the UK National Health Service (NHS) team to understand their rationale for adopting an opt-out system and their lessons since transitioning to a presumed consent system. The discussion will include leading experts from the United States who will provide their insights and share their opinions on both systems. Our panelist will address misunderstandings and uncertainties about both methods and assess trends in global organ donation policies, implications of cultural attitudes towards donation, and potential health disparities.